Federated Hermes, Inc. Astrazeneca PLC Transaction History
Federated Hermes, Inc.
- $52.5 Billion
- Q3 2025
A detailed history of Federated Hermes, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Federated Hermes, Inc. holds 118,013 shares of AZN stock, worth $10.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
118,013
Previous 155,007
23.87%
Holding current value
$10.6 Million
Previous $10.8 Million
16.42%
% of portfolio
0.02%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,502Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...